59 related articles for article (PubMed ID: 28883694)
1. Cytoplasmic domain of tissue factor promotes liver fibrosis in mice.
Knight V; Lourensz D; Tchongue J; Correia J; Tipping P; Sievert W
World J Gastroenterol; 2017 Aug; 23(31):5692-5699. PubMed ID: 28883694
[TBL] [Abstract][Full Text] [Related]
2. Liver fibrosis is driven by protease-activated receptor-1 expressed by hepatic stellate cells in experimental chronic liver injury.
Poole LG; Pant A; Cline-Fedewa HM; Williams KJ; Copple BL; Palumbo JS; Luyendyk JP
Res Pract Thromb Haemost; 2020 Jul; 4(5):906-917. PubMed ID: 32685902
[TBL] [Abstract][Full Text] [Related]
3. Chronic liver injury drives non-traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase.
Poole LG; Pant A; Baker KS; Kopec AK; Cline-Fedewa HM; Iismaa SE; Flick MJ; Luyendyk JP
J Thromb Haemost; 2019 Jan; 17(1):113-125. PubMed ID: 30415489
[TBL] [Abstract][Full Text] [Related]
4. Profibrogenic role of IL-15 through IL-15 receptor alpha-mediated trans-presentation in the carbon tetrachloride-induced liver fibrosis model.
Cloutier M; Variya B; Akbari SA; Rexhepi F; Ilangumaran S; Ramanathan S
Front Immunol; 2024; 15():1404891. PubMed ID: 38919611
[TBL] [Abstract][Full Text] [Related]
5. Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin.
Shearer AM; Rana R; Austin K; Baleja JD; Nguyen N; Bohm A; Covic L; Kuliopulos A
J Biol Chem; 2016 Oct; 291(44):23188-23198. PubMed ID: 27613872
[TBL] [Abstract][Full Text] [Related]
6. Secreted folate receptor γ drives fibrogenesis in metabolic dysfunction-associated steatohepatitis by amplifying TGFβ signaling in hepatic stellate cells.
Quinn C; Rico MC; Merali C; Barrero CA; Perez-Leal O; Mischley V; Karanicolas J; Friedman SL; Merali S
Sci Transl Med; 2023 Sep; 15(715):eade2966. PubMed ID: 37756380
[TBL] [Abstract][Full Text] [Related]
7. Coagulation factor VII and malignant progression of hepatocellular carcinoma.
Chen KD; Huang KT; Tsai MC; Wu CH; Kuo IY; Chen LY; Hu TH; Chen CL; Lin CC
Cell Death Dis; 2016 Feb; 7(2):e2110. PubMed ID: 26913602
[No Abstract] [Full Text] [Related]
8. Glycosylation-dependent galectin-1/neuropilin-1 interactions promote liver fibrosis through activation of TGF-β- and PDGF-like signals in hepatic stellate cells.
Wu MH; Chen YL; Lee KH; Chang CC; Cheng TM; Wu SY; Tu CC; Tsui WL
Sci Rep; 2017 Sep; 7(1):11006. PubMed ID: 28887481
[TBL] [Abstract][Full Text] [Related]
9. NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL-17 and TNF in mice.
Wree A; McGeough MD; Inzaugarat ME; Eguchi A; Schuster S; Johnson CD; Peña CA; Geisler LJ; Papouchado BG; Hoffman HM; Feldstein AE
Hepatology; 2018 Feb; 67(2):736-749. PubMed ID: 28902427
[TBL] [Abstract][Full Text] [Related]
10. 5-Aza-2'-deoxycytidine induces human Tenon's capsule fibroblasts differentiation and fibrosis by up-regulating TGF-β type I receptor.
Fu S; Sun L; Zhang X; Shi H; Xu K; Xiao Y; Ye W
Exp Eye Res; 2017 Dec; 165():47-58. PubMed ID: 28893564
[TBL] [Abstract][Full Text] [Related]
11. Improving Management of Portal Hypertension: The Potential Benefit of Non-Etiological Therapies in Cirrhosis.
Bitto N; Ghigliazza G; Lavorato S; Caputo C; La Mura V
J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769582
[TBL] [Abstract][Full Text] [Related]
12.
Ma X; Liu Z; Yu Y; Jiang Y; Wang C; Zuo Z; Ling S; He M; Cao S; Wen Y; Zhao Q; Wu R; Huang X; Zhong Z; Peng G; Gu Y
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233337
[No Abstract] [Full Text] [Related]
13. The Therapeutic Potential of Anticoagulation in Organ Fibrosis.
Oh H; Park HE; Song MS; Kim H; Baek JH
Front Med (Lausanne); 2022; 9():866746. PubMed ID: 35652066
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor cytoplasmic domain exacerbates post-infarct left ventricular remodeling via orchestrating cardiac inflammation and angiogenesis.
Chong SY; Zharkova O; Yatim SMJM; Wang X; Lim XC; Huang C; Tan CY; Jiang J; Ye L; Tan MS; Angeli V; Versteeg HH; Dewerchin M; Carmeliet P; Lam CSP; Chan MY; de Kleijn DPV; Wang JW
Theranostics; 2021; 11(19):9243-9261. PubMed ID: 34646369
[TBL] [Abstract][Full Text] [Related]
15. Antisense Tissue Factor Oligodeoxynucleotides Protected Diethyl Nitrosamine/Carbon Tetrachloride-Induced Liver Fibrosis Through Toll Like Receptor4-Tissue Factor-Protease Activated Receptor1 Pathway.
Shouman MM; Abdelsalam RM; Tawfick MM; Kenawy SA; El-Naa MM
Front Pharmacol; 2021; 12():676608. PubMed ID: 34045968
[TBL] [Abstract][Full Text] [Related]
16. Gli3 is a novel downstream target of miR‑200a with an anti‑fibrotic role for progression of liver fibrosis in vivo and in vitro.
Li L; Ran J; Li L; Chen G; Zhang S; Wang Y
Mol Med Rep; 2020 Apr; 21(4):1861-1871. PubMed ID: 32319630
[TBL] [Abstract][Full Text] [Related]
17. GPCR-induced YAP activation sensitizes fibroblasts to profibrotic activity of TGFβ1.
Zmajkovicova K; Bauer Y; Menyhart K; Schnoebelen M; Freti D; Boucher M; Renault B; Studer R; Birker-Robaczewska M; Klenk A; Nayler O; Gatfield J
PLoS One; 2020; 15(2):e0228195. PubMed ID: 32053631
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-152 contributes to the progression of liver fibrosis via targeting Gli3
Li L; Zhang L; Zhao X; Cao J; Li J; Chu G
Exp Ther Med; 2019 Jul; 18(1):425-434. PubMed ID: 31258681
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl
Zhang Y; Li R; Rong W; Han M; Cui C; Feng Z; Sun X; Jin S
Cell Death Dis; 2018 Dec; 9(12):1186. PubMed ID: 30538216
[TBL] [Abstract][Full Text] [Related]
20. Coagulation, Microenvironment and Liver Fibrosis.
Bitto N; Liguori E; La Mura V
Cells; 2018 Jul; 7(8):. PubMed ID: 30042349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
